Expertise in
8
conditions

Andrew P. Sharp

Cardiff, WLS, GB 
Expertise in
8
conditions
Cardiff, WLS, GB 

Overview

Andrew Sharp practices practicing medicine in Cardiff, United Kingdom.

Mr. Sharp is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Hypertension, Stable Angina, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

He is actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Cardiff, WLS, United Kingdom
Other Locations
Exeter, ENG, United Kingdom
Leicester, ENG, United Kingdom
St. Leonards On Sea, Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Completed
Publish Date: July 30, 2026
Intervention Type: Device, Procedure
Study Phase: Not Applicable
OPtimizaTIon of Left MAin PCI With IntravascuLar Ultrasound. The OPTIMAL Randomized Controlled Trial
OPtimizaTIon of Left MAin PCI With IntravascuLar Ultrasound. The OPTIMAL Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: June 23, 2026
Intervention Type: Device
Study Phase: Not Applicable
The RADIANCE-HTN Study. A Study of the ReCor Medical Paradise System in Clinical Hypertension
The RADIANCE-HTN Study. A Study of the ReCor Medical Paradise System in Clinical Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: April 21, 2026
Intervention Type: Device
Study Phase: Not Applicable
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease
Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease
Enrollment Status: Completed
Publish Date: January 22, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

122 Total Publications

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
Journal: The New England journal of medicine
Published: March 30, 2026

Frequently Asked Questions about Andrew P. Sharp

Is Andrew P. Sharp a top-rated expert for Pulmonary Embolism?

MediFind is an objective health platform that identifies experts based on real-world data. Andrew P. Sharp is classified as an Distinguished expert for Pulmonary Embolism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrew P. Sharp participate in research or clinical trials?

Yes. Andrew P. Sharp has published 122 articles and abstracts on conditions like Pulmonary Embolism. You can view a list of Andrew P. Sharp's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sharp's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile